T. Rowe Price Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.7M | Buy |
|
|||||
|
2025
Q2 | $27M | Buy |
|
|||||
|
2025
Q1 | $22.7M | Buy |
|
|||||
|
2024
Q4 | $27.7M | Buy |
|
|||||
|
2024
Q3 | $26.4M | Sell |
|
|||||
|
2024
Q2 | $28.8M | Sell |
|
|||||
|
2024
Q1 | $48M | Buy |
|
|||||
|
2023
Q4 | $34.7M | Sell |
|
|||||
|
2023
Q3 | $46.6M | Sell |
|
|||||
|
2023
Q2 | $44.4M | Buy |
|
|||||
|
2023
Q1 | $40.2M | Buy |
|
|||||
|
2022
Q4 | $38.2M | Buy |
|
|||||
|
2022
Q3 | $30.1M | Buy |
|
|||||
|
2022
Q2 | $20.7M | Buy |
|
|||||
|
2022
Q1 | $18M | Sell |
|
|||||
|
2021
Q4 | $17.2M | Sell |
|
|||||
|
2021
Q3 | $24.8M | Sell |
|
|||||
|
2021
Q2 | $37.1M | Buy |
|
|||||
|
2021
Q1 | $61.3M | Sell |
|
|||||
|
2020
Q4 | $72.2M | Sell |
|
|||||
|
2020
Q3 | $53.5M | Sell |
|
|||||
|
2020
Q2 | $55.9M | Sell |
|
|||||
|
2020
Q1 | $62.7M | Buy |
|
|||||
|
2019
Q4 | $71.9M | Sell |
|
|||||
|
2019
Q3 | $79.1M | Buy |
|
|||||
|
2019
Q2 | $72.6M | Buy |
|
|||||
|
2019
Q1 | $44.4M | Sell |
|
|||||
|
2018
Q4 | $55.9M | Sell |
|
|||||
|
2018
Q3 | $94.7M | Buy |
|
|||||
|
2018
Q2 | $50.1M | Sell |
|
|||||
|
2018
Q1 | $65.3M | Sell |
|
|||||
|
2017
Q4 | $88.5M | Sell |
|
|||||
|
2017
Q3 | $117M | Sell |
|
|||||
|
2017
Q2 | $128M | Sell |
|
|||||
|
2017
Q1 | $141M | Sell |
|
|||||
|
2016
Q4 | $217M | Sell |
|
|||||
|
2016
Q3 | $199M | Buy |
|
|||||
|
2016
Q2 | $156M | Buy |
|
|||||
|
2016
Q1 | $163M | Buy |
|
|||||
|
2015
Q4 | $86.2M | Buy |
|
|||||
|
2015
Q3 | $59.8M | Buy |
|
|||||
|
2015
Q2 | $74.4M | Buy |
|
|||||
|
2015
Q1 | $58M | Buy |
|
|||||
|
2014
Q4 | $48.1M | Buy |
|
|||||
|
2014
Q3 | $35.5M | Buy |
|
|||||
|
2014
Q2 | $571K | Sell |
|
|||||
|
2014
Q1 | $612K | Hold |
|
|||||
|
2013
Q4 | $791K | Buy |
|
|||||
|
2013
Q3 | $601K | Hold |
|
|||||
|
2013
Q2 | $624K | Buy |
|